Avidian Wealth Enterprises’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$935K Buy
10,203
+727
+8% +$63.6K 0.03% 338
2026
Q1
$808K Buy
9,476
+1,857
+24% +$166K 0.03% 330
2025
Q4
$602K Sell
7,619
-1,449
-16% -$114K 0.02% 337
2025
Q3
$725K Buy
9,068
+162
+2% +$13.8K 0.03% 283
2025
Q2
$810K Buy
8,906
+212
+2% +$19.4K 0.03% 238
2025
Q1
$815K Buy
8,694
+1,187
+16% +$106K 0.04% 223
2024
Q4
$682K Sell
7,507
-121
-2% -$11.5K 0.03% 242
2024
Q3
$792K Sell
7,628
-510
-6% -$52K 0.04% 221
2024
Q2
$790K Buy
8,138
+547
+7% +$50.5K 0.03% 215
2024
Q1
$684K Sell
7,591
-1,611
-18% -$136K 0.03% 213
2023
Q4
$733K Buy
9,202
+219
+2% +$16.5K 0.05% 199
2023
Q3
$639K Sell
8,983
-4,193
-32% -$314K 0.05% 214
2023
Q2
$1.02M Sell
13,176
-63
-0.5% -$4.88K 0.07% 176
2023
Q1
$995K Buy
13,239
+1,230
+10% +$91.5K 0.05% 201
2022
Q4
$946K Buy
12,009
+625
+5% +$46.9K 0.06% 186
2022
Q3
$800K Buy
11,384
+39
+0.3% +$3.06K 0.06% 174
2022
Q2
$909K Buy
11,345
+130
+1% +$10.2K 0.06% 179
2022
Q1
$850K Buy
11,215
+239
+2% +$18.9K 0.05% 219
2021
Q4
$937K Buy
10,976
+91
+0.8% +$7.11K 0.06% 200
2021
Q3
$823K Buy
10,885
+178
+2% +$14.1K 0.06% 152
2021
Q2
$871K Sell
10,707
-11,273
-51% -$922K 0.07% 145
2021
Q1
$1.73M Sell
21,980
-558
-2% -$43.7K 0.15% 88
2020
Q4
$1.93M Buy
22,538
+643
+3% +$53.2K 0.18% 79
2020
Q3
$1.69M Buy
21,895
+1,172
+6% +$89.4K 0.19% 78
2020
Q2
$1.52M Buy
20,723
+600
+3% +$42.6K 0.2% 74
2020
Q1
$1.33M Sell
20,123
-65
-0.3% -$4.58K 0.21% 61
2019
Q4
$1.39M Buy
20,188
+15,926
+374% +$1.09M 0.2% 52
2019
Q3
$313K Buy
4,262
+196
+5% +$14.2K 0.05% 144
2019
Q2
$291K Buy
4,066
+887
+28% +$63K 0.07% 110
2019
Q1
$218K Buy
+3,179
New +$205K 0.05% 119

Other funds holding CL

Avidian Wealth Enterprises's CL Position: Q2 2026 in Review

Avidian Wealth Enterprises increased its Colgate-Palmolive (CL) stake by 7.7% in Q2 2026, buying an estimated $63.6K and bringing the position to 10,203 shares worth $935K. The position accounts for 0.03% of the portfolio, ranked #338.

Avidian Wealth Enterprises first reported a position in CL in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.93M in Q4 2020. 606 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Avidian Wealth Enterprises held 10,203 shares of Colgate-Palmolive worth $935K as of Q2 2026.
  • Avidian Wealth Enterprises bought 727 Colgate-Palmolive shares in Q2 2026, an estimated $63.6K.
  • Colgate-Palmolive made up 0.03% of Avidian Wealth Enterprises's portfolio in Q2 2026, its #338 holding.
  • Avidian Wealth Enterprises first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 30 quarters since.
  • Avidian Wealth Enterprises's Colgate-Palmolive position peaked at $1.93M in Q4 2020.
  • 606 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q2 2026, filed 24 Jul 2026.